Discovery Laboratories, no future here for years to come. Discovery Laboratories said July 1st that its lead drug candidate, a treatment for respiratory distress syndrome in premature infants called Surfaxin, faces “a significant hurdle for approval.” The share price plummeted over 50%
The market has a tendency to overreact to both good and bad news. So right now DSCO is looking cheap just for extremely short term day bounce. I don't see much else happening. After an FDA denial investors get scared away and product development will slowly disappear.
I was never a fan of DSCO's drug Surfaxin for infants which is used to imitate the function of the lung’s natural surfactants, fluids with a soapy consistency that reduce friction and help breathing. I think drugs for fatally sick persons are much easier to get approved in comparison to a drug for infants. The use of medication on infants to me is a delicate issue, it has little to do with science and all to do with emotion and the public's acceptance of this idea.
DSCO pipeline is not so great, almost everything in the pipeline is based around Surfaxin. I have not looked at the drugs data, but if Surfaxin does not get approved for RDS the probability of it getting approved for Bronchopulmonary Dysplasia (BPD) or Acute Respiratory Failure (ARF) go down significantly IMO. Here is a chart of DSCO's current pipeline
Since their other drugs are far from completion I would say look forward to more stock offerings and other forms of dilution.

Again, no future here for years to come unless your going to be doing some day trading during these volatile time or looking for the possibility of quick short term bounce.
If your into holding stocks for years then this might be for you. If not, then there are much better picks out there.